429 related articles for article (PubMed ID: 1799382)
1. Antigenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
Shibata K; Matsuda K; Wada H; Aruga F; Yamada Y
Arzneimittelforschung; 1991 Oct; 41(10):1048-52. PubMed ID: 1799382
[TBL] [Abstract][Full Text] [Related]
2. [Antigenicity study of trandolapril (RU44570)].
Aruga F; Yamada Y; Iwaskai S; Hongo Y; Kato M; Wada H; Ishihara R
J Toxicol Sci; 1993 Feb; 18 Suppl 1():161-75. PubMed ID: 8515501
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
Shibata K; Matsuda K; Ohta T; Sasaki Y; Sutou S
Arzneimittelforschung; 1991 Oct; 41(10):1053-7. PubMed ID: 1799383
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity of the new quinolone antibacterial agent levofloxacin.
Wagai N; Hattori H; Yamaguchi F; Takayama S
Arzneimittelforschung; 1992 Mar; 43(3A):385-9. PubMed ID: 1622437
[TBL] [Abstract][Full Text] [Related]
5. Reproductive and developmental toxicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc].
Matsuda K; Nishi N; Hiramatsu Y; Shimizu M; Ohta T; Kato M
Arzneimittelforschung; 1991 Oct; 41(10):1042-8. PubMed ID: 1799381
[TBL] [Abstract][Full Text] [Related]
6. Antigenicity study of the new cognition-enhancing agent nefiracetam.
Wagai N; Yamaguchi F; Hasegawa T; Takayama S
Arzneimittelforschung; 1994 Feb; 44(2A):247-50. PubMed ID: 8018098
[TBL] [Abstract][Full Text] [Related]
7. Single dose toxicity study on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc] in mice and rats.
Matsuda K; Shibata K; Morikami H; Kato T; Aruga F
Arzneimittelforschung; 1991 Oct; 41(10):1033-5. PubMed ID: 1799379
[TBL] [Abstract][Full Text] [Related]
8. Study on the metabolic fate of catena-(S)-[mu-N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 3rd communication: transfer into fetus and milk in rats.
Toyama S; Furuta S; Miwa M; Suzuki M; Sano H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):984-91. PubMed ID: 1796929
[TBL] [Abstract][Full Text] [Related]
9. [Antigenicity test of cefodizime sodium].
Takemoto M; Matsuo K; Katoh S; Yoshida R
J Toxicol Sci; 1988 Jun; 13 Suppl 1():231-43. PubMed ID: 3172292
[TBL] [Abstract][Full Text] [Related]
10. [Antigenicity study of carboplatin in guinea pigs and mice].
Kawano S; Kohmura H; Ohta S; Takahashi N
J Toxicol Sci; 1988 Jul; 13 Suppl 2():1-21. PubMed ID: 3054128
[TBL] [Abstract][Full Text] [Related]
11. [Antigenicity study of buspirone hydrochloride in guinea pigs and mice].
Kawano S; Kohmura H; Ohta S; Takahashi N
J Toxicol Sci; 1990 Apr; 15 Suppl 1():15-30. PubMed ID: 2376868
[TBL] [Abstract][Full Text] [Related]
12. Antigenicity study of muroctasin.
Yamaguchi F; Hattori H; Wagai N; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
[TBL] [Abstract][Full Text] [Related]
13. Repeated dose toxicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc] in rats.
Matsuda K; Mera Y; Wada H; Aruga H; Saik Y; Taniguchi Y
Arzneimittelforschung; 1991 Oct; 41(10):1036-41. PubMed ID: 1799380
[TBL] [Abstract][Full Text] [Related]
14. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 2nd communication: absorption, distribution, metabolism and excretion after repeated administration to rats.
Toyama S; Furuta S; Miwa M; Suzuki M; Sano H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):976-83. PubMed ID: 1796928
[TBL] [Abstract][Full Text] [Related]
15. [Immunological properties of S-1090, cefmatilen hydrochloride hydrate].
Takeuchi M; Harada M; Nagata M; Watanabe A; Nakamura K
J Toxicol Sci; 2001 May; 26 Suppl 1():231-42. PubMed ID: 11400315
[TBL] [Abstract][Full Text] [Related]
16. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 4th communication: disposition of zinc and amino acids in rats, dogs and monkeys.
Furuta S; Toyama S; Miwa M; Ikeda Y; Sano H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):992-5. PubMed ID: 1796930
[TBL] [Abstract][Full Text] [Related]
17. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity tests on propiverine hydrochloride in guinea pigs and mice.
Kouchi Y; Imamura K; Izumi K; Yoshida R
J Toxicol Sci; 1989 May; 14(2):143-51. PubMed ID: 2778854
[TBL] [Abstract][Full Text] [Related]
19. [Antigenicity tests of a new antineoplastic agent S-1].
Maeda Y; Morinaga H; Izumi K; Ikebuchi K; Kouchi Y
J Toxicol Sci; 1996 Nov; 21 Suppl 3():661-73. PubMed ID: 9021667
[TBL] [Abstract][Full Text] [Related]
20. [Antigenicity study of paclitaxel].
Kawano S; Ishikawa K; Kohmura H; Kadota T; Takahashi N
J Toxicol Sci; 1994 Aug; 19 Suppl 1():113-22. PubMed ID: 7966458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
